Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. News
  7. Summary
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sino Biopharmaceutical : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy

03/30/2021 | 05:11am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about SINO BIOPHARMACEUTICAL LIMITED
06:39aChina Accepts Sino Biopharm's Marketing Application for Cancer Drug
MT
01:41aSino Biopharm Buys Back $278 Million of Euro-Denominated Bonds
MT
05/23Sino Biopharmaceutical Submits Application for Marketing of the Category I Anti-Tumor I..
CI
05/23Sino Biopharm Repurchases $168 Million of Euro-Denominated Bonds
MT
05/19Sino Biopharm Unit to Purchase Tumor Inhibitor of Danish Biotech Firm Symphogen
MT
05/11Hong Kong Stocks Rebound from Near Two-Month Low; Biotech Shares Rally
MT
05/06UBS Adjusts Sino Biopharmaceutical's Price Target to HK$8 From HK$11.6, Keeps at Buy
MT
05/05Sino Biopharm Repurchases $86.5 Million of Euro-Denominated Bonds
MT
04/25Sino Biopharmaceutical Signs License Deal for Hepatitis, Diabetes Drugs
MT
04/20Sino Biopharm Gets Clearance to Start China Clinical Trial of Anti-Tumor Drug
MT
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIMITED
More recommendations
Financials
Sales 2022 37 731 M 4 807 M 4 807 M
Net income 2022 6 584 M 839 M 839 M
Net cash 2022 6 140 M 782 M 782 M
P/E ratio 2022 12,4x
Yield 2022 1,63%
Capitalization 79 179 M 10 087 M 10 087 M
EV / Sales 2022 1,94x
EV / Sales 2023 1,41x
Nbr of Employees 25 579
Free-Float 52,2%
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | 1177 | KYG8167W1380 | MarketScreener
Technical analysis trends SINO BIOPHARMACEUTICAL LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 4,24 HKD
Average target price 8,21 HKD
Spread / Average Target 93,6%
EPS Revisions
Managers and Directors
Yi Li Chief Executive Officer & Executive Director
Jia yin Ma Group Chief Financial Officer
Theresa Tse Chairman
Mao Li Chief Medical Officer
Zheng Fei Lu Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SINO BIOPHARMACEUTICAL LIMITED-21.06%10 253
JOHNSON & JOHNSON4.89%472 179
PFIZER, INC.-10.45%296 704
ROCHE HOLDING AG-14.40%273 052
ELI LILLY AND COMPANY9.55%272 388
ABBVIE INC.9.33%261 585